1. Home
  2. PLUS vs RXRX Comparison

PLUS vs RXRX Comparison

Compare PLUS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ePlus inc.

PLUS

ePlus inc.

N/A

Current Price

$95.07

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

N/A

Current Price

$3.54

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLUS
RXRX
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
PLUS
RXRX
Price
$95.07
$3.54
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $7.32
AVG Volume (30 Days)
219.8K
★ 21.4M
Earning Date
11-05-2026
11-02-2026
Dividend Yield
★ 1.14%
N/A
EPS Growth
★ 24.20
14.79
EPS
★ 2.72
N/A
Revenue
★ $2,442,549,000.00
$74,681,000.00
Revenue This Year
$4.67
N/A
Revenue Next Year
$4.89
$49.16
P/E Ratio
$34.71
★ N/A
Revenue Growth
18.07
★ 26.92
52 Week Low
$73.09
$2.77
52 Week High
$98.21
$5.24

Technical Indicators

Market Signals
Indicator
PLUS
RXRX
Relative Strength Index (RSI) 54.64 45.11
Support Level $85.87 $2.90
Resistance Level $98.03 $3.66
Average True Range (ATR) 4.31 0.33
MACD -0.13 -0.04
Stochastic Oscillator 84.64 10.50

Price Performance

Historical Comparison
PLUS
RXRX

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Share on Social Networks: